Abacavir, dolutegravir, and lamivudine and Sodium Bicarbonate Injection
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Sodium Bicarbonate Injection and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Dolutegravir and sodium bicarbonate should not be taken orally at the same time. Products that contain aluminum, calcium, iron, magnesium and/or other minerals may interfere with the absorption of dolutegravir and reduce its effectiveness in treating HIV infection. You should take dolutegravir at least two hours before or six hours after the sodium bicarbonate dose. Talk to your doctor if you have any questions or concerns, or if you have trouble separating the dosing times. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:ADJUST DOSING INTERVAL: Coadministration with medications containing polyvalent cations such as aluminum, calcium, iron, or magnesium may decrease the oral bioavailability of dolutegravir. The mechanism of interaction has not been established. In 16 study subjects, administration of a single 50 mg dose of dolutegravir simultaneously with an antacid (Maalox) decreased dolutegravir peak plasma concentration (Cmax), systemic exposure (AUC) and trough plasma concentration (Cmin; 24 hours post-dose) by 72%, 74% and 74%, respectively, compared to administration without the antacid. When the antacid was administered 2 hours after dolutegravir, the Cmax, AUC and Cmin of dolutegravir decreased by just 18%, 26% and 30%, respectively. Administration of single-dose dolutegravir simultaneously with a multivitamin (One-A-Day) decreased the Cmax, AUC and Cmin of dolutegravir by 35%, 33% and 32%, respectively.
MANAGEMENT: Dolutegravir should be administered 2 hours before or 6 hours after medications containing polyvalent cations such as antacids, laxatives, or mineral supplements.
- "Product Information. Tivicay (dolutegravir)." ViiV Healthcare, Research Triangle Park, NC.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: sodium bicarbonate
Brand name: Neut
Synonyms: Sodium bicarbonate, Sodium Bicarbonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Sodium bicarbonate Oral, Intravenous, Subcutaneous
- Abacavir, dolutegravir, and lamivudine-Sodium Bicarbonate Tablets
- Abacavir, dolutegravir, and lamivudine-Sodium Bicarbonate, Citric Acid, and Simethicone Effervescent Granule Pkt
- Abacavir, dolutegravir, and lamivudine-Sodium biphosphate and sodium phosphate
- Abacavir, dolutegravir, and lamivudine-Sodium biphosphate and sodium phosphate rectal
- Abacavir, dolutegravir, and lamivudine-Sodium cellulose phosphate
- Sodium Bicarbonate Injection-Abacavir, Lamivudine and Zidovudine Tablets
- Sodium Bicarbonate Injection-Abacavir, lamivudine, and zidovudine
- Sodium Bicarbonate Injection-Abaloparatide
- Sodium Bicarbonate Injection-Abaloparatide Subcutaneous
- Sodium Bicarbonate Injection-Abatacept
- Sodium Bicarbonate Injection-Abatacept Auto-Injectors